Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Yr4: Neurology & Special Senses > Dermatology: Skin Cancer > Flashcards

Dermatology: Skin Cancer Flashcards

1
Q

DECK DIRECTLY COPIED FROM CANCER CARE

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

State the skin cancers you need to know

A
  • Melanoma
  • Basal cell carcinoma
  • Squamous cell carcinoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What cells do basal cell carcinomas arise from?

A

Slow-growing, locally invasive epidermal skin tumour arising from the stratum basale (used to think originated from basal cell but recently discovered you can get it anywhere other than lip therefore has hair follicle origin)

***The lowest layer of the epidermis is called the basal layer. It contains rounder cells called basal cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

State some risk factors for BCC

A
  • Fitzpatrick skin types I & II
  • UV exposure
  • Increasing age
  • Smoking
  • Immunosuppression
  • Male
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State the 5 types of BCC; including which subtypes are low risk and which are high risk

Highlight the most common subtype?

A

Risk depends on many factors but generally nodular and superficial considered less risky

  • Nodular (nBCC)
  • Superficial (sBCC)
  • Morpheic/sclerosing
  • Basosquamous
  • Pigmented
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Order the following skin cancers from most common to least common:

  • BCC
  • Melanoma
  • SCC
A
  • BCC (80%)
  • SCC
  • Melanoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

If someone has multiple BCCs presenting at a young age, what autosomal dominant condition might this be?

A

Basal cell naevus (Gorlin) syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the typical presentation of of nodular basal cell carcinoma

A
  • Pearly (shiny) nodule with telangiectasia
  • Rolled edge
  • Tends to ulcerate with time
  • Common on head & neck region
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the typical presentation of superficial basal cell carcinoma

A
  • Erythematous irregular patch or plaque
  • Slightly scaly
  • Usually on trunk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the typical presentation of morpheic/sclerosing basal cell carcinoma

A
  • Shiny, scar-like plaque
  • Ill-defined border
  • Usually found in mid-facial sites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Basosquamous carcinoma is rare; what is it?

A
  • Mixed basal cell carcinoma (BCC) and squamous cell carcinoma (SCC)
  • Infiltrative growth pattern
  • Potentially more aggressive than other forms of BCC
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Discuss the 2WW referral criteria for BCC

A
  • Only consider urgent referral (2WW) if has skin lesion suggestive of BCC AND there’s concern that a delay may have unfavourable impact due to location or size of lesion
  • In others, arrange a routine referral
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Discuss what investigations are done for BCC

A

Diagnosis usually made clinically, biopsy only indicated if clinical doubt exists or when histological subtype may influence treatment & prognosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Discuss the management of BCC (highlight the most common management/treatment of choice)

A
  • Surgical excision with histological assessment of the margins (target excision depends on subtype)
  • Moh’s surgery (for high risk facial BCCs)
  • Destructive surgical techniques (small nodular or superficial)
    • Curettage (scrape)
    • Cryosurgery (extreme cold)
  • Radiotherapy
  • Destructive non-surgical techniques
    • Topical imiquimod (sBCCs)
    • Topical fluorouracil (sBCCs)
    • Photodynamic therapy (sBCCs)

And of course skin protection advice (cover up, sun cream etc…)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Discuss the prognosis of BCC

A
  • Very good prognosis (85-90% don’t get recurrence)
  • Almost never a danger to life
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What cells do squamous cell carcinoma arise from?

A

Cutaneous carcinoma arising from keratinocytes of the epidermis or it’s appendages

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

State some risk factors for squamous cell carcinoma

A
  • Fitzpatrick skin types (I & II)
  • Chronic UV radiation
  • Smoking
  • Immunosuppression
  • Increasing age
  • Male
  • Genetic conditions (e.g. xeroderma pigmentosum, albinism)
  • Chronic inflammation or chronic wounds (e.g. long standing leg ulcers [Marjolin’s ulcer])
  • HPV (for genital or anal SCC)
  • Actinic keratosis
  • Bowen disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is actinic keratosis?

A
  • Common premalignant skin condition that arises due to chronic sun exposure
  • Presentation:
    • Small, crusty or scaly lesions
    • May be pink, red, brown or same colour as skin
    • On sun exposed areas (e.g. face)
    • May have multiple lesions

AK is an epidermal lesion characterized by aggregates of atypical, pleomorphic keratinocytes at the basal layer that may extend upwards to involve the granular and cornified layers. This presentation may resemble Bowen disease or carcinoma in situ, and the distinction between the two is a matter of degree (extent of the lesion) rather than differences in individual cells.**

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is Bowen disease/SCC in situ?

A
  • Squamous cell carcinoma that is confined to the epidermis (with basement membrane intact)
  • Presentation:
    • Red or pink patch or plaque
    • Scaly or crusty
    • Might be intermittently itchy
    • Common in sun-exposed areas
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Describe typical presentation of SCC

A
  • Indurating (hard) keratinising or crusted plaque or nodule
  • Commonly in sun exposed sites (e.g. face, forearms, dorsum of hands)
  • Often symptomatic:
    • Pain
    • Discomfort
    • Bleeding
    • Ulcerating
    • Sensory changes

*NOTE: SCCs have different morphologies:

  • Well differentiated: scaly and grows slowly
  • Poorly differentiated: non-scaly, appear rlike granulation tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Discuss the 2WW referral criteria for SCC

A

Refer via 2WW if person has lesion suspicious of SCC

22
Q

What investigations are done for SCC?

A

Biopsy

(helps differentiate e.g. Bowen disease, SCC etc… In SCC would see keratinocyte atypia that invades basement membrane and invasion into dermis. In Bowen disease would see keratinocyte atypia confined to epidermis with intact basement membrane)

For high risk SCCs may consider additional investigations to look for metastases e.g. CT TAP, MRI, PET scan etc…

23
Q

Discuss the management of SCC

A

Treatment depends on whether SCC is classified as low risk or high risk (based on clinical & histological features):

  • Most are treated with surgical excision
    • 4mm margin if low risk or <20mm lesion
    • 6mm margin if high risk or >20mm lesion
  • Moh’s surgery may be used in high risk SCC’s and in cosmetically important sites
  • Radiotherapy if non-resectable

And of course skin protection advice (cover up, sun cream etc…)

24
Q

Discuss the prognosis of SCC

State some good and some poor prognostic factors

A

Prognosis generally very good

25
Q

What is Moh’s surgery?

A

Staged resection in which thin layers of skin are progressively removed. Once removed the layers are examined under a microscope. Keep removing layers until only cancer free tissue remains. Usually done under LA.(This differs from surgical excision in which they excise the lesion with a set margin e.g. 4mm or 6mm)

26
Q

Discuss the management of actinic keratosis and Bowen disease

A

Options include:

  • Moisturisers and sun protection
  • Topical treatments (e.g. 5-flurouracil for 4 weeks, imiquimod, diclofenac)
  • Cryotherapy
  • Curettage & cautery
  • Photodynamic therapy
  • Actinic keratosis may just be observed if indicated
  • *5-FU can make skin red & inflamed hence sometimes topical hydrocortisone is given following 5-FU treatment*
  • **Topical therapy & cryosurgery first line for most*
  • ***Photodynamic therapy (PDT) is a technique for treating skin cancers and sundamaged skin which might one day turn cancerous (pre-cancers). In PDT a special light activates a cream which has been applied to the lesion (affected area of skin). This treatment kills the abnormal cells in the skin.*
27
Q

Compare:

  • Actinic keratosis
  • Bowen’s disease
  • SCC
A
  • AK: atypical keratinocytes that appear to crowd the basal layer and lower levels of the epidermis, but do not extend to full thickness
  • Bowen’s: full-thickness atypia that is confined to the epidermis, with an intact basement membrane
  • SCC: Extend beyond the basement membrane, penetrate into the dermis, and may invade deeper structures
28
Q

Compare:

  • Actinic keratosis
  • Bowen’s disease
  • SCC
A
  • AK: atypical keratinocytes that appear to crowd the basal layer and lower levels of the epidermis, but do not extend to full thickness
  • Bowen’s: full-thickness atypia that is confined to the epidermis, with an intact basement membrane
  • SCC: Extend beyond the basement membrane, penetrate into the dermis, and may invade deeper structures
29
Q

What cells does melanoma arise from?

A

Malignant tumour arising from melanocytes (found in basal layer of epidermis)

30
Q

What’s the median age of diagnosis for melanoma?

A

61yrs

31
Q

State some risk factors for melanoma

A
  • UV radiation (increased exposure, previous sunburn)
  • Fitzpatrick skin types (I-III)
  • FH
  • Personal history or melanoma
  • Having multiple pigmented naevi
  • Giant congenital melanocytic vaevus
32
Q

State the 4 subtypes of melanoma and state whether each is predominantly radial growing or predominantly vertical growing

A

Predominantly radial growing

  • Superficial spreading melanoma
  • Acral lentiginous melanoma
  • Lentigo maligna melanoma

Predominantly vertical growing

  • Nodular melanoma
33
Q

Describe the typical presentation of lentigo maligna melanoma

A
  • Hyperpigmented patch or plaque (mole) growing radially following ABCDE rules
    • Asymmetry, irregular border, multi-coloured, diameter >0.6cm, evolution
  • Occurs in sun exposed regions
  • Older/elderly people
34
Q

Describe the typical presentation of acral lentiginous melanoma

A
  • Affects nails, palms or soles
  • Hutchinson sign (extension of pigment into nailfold)
  • More common in Afro-Caribbean & asian people
35
Q

Describe the typical presentation of superficial spreading melanoma

A
  • Hyperpigmented patch or plaque (mole) growing radially following ABCDE rules:
    • Asymmetry, irregular border, multi-coloured, diameter >0.6cm, evolution
  • Commonly on arms, legs, back and & chest
  • Can occur in young people
36
Q

Describe the typical presentation of nodular melanoma

A
  • Hyperpigmented or blue/black or amelanotic firm papule, nodule or plaque
  • May bleed or ooze
  • Occurs in sun exposed sites
  • Middle-aged people
37
Q

What ‘rule’ do predominantly radial growing melanomas follow?

A

ABDE rules

  • Asymmetry
  • Irregular border (1. pattern in which lesions extends out in surrounding skin e.g. can you draw nice smooth line around it or is it wiggly? 2. Definition of the border- is the border distinct or are there areas where it merges/fades into surrounding skin? Poorly defined more likely to be aggressive malignancy)
  • Multi-coloured (difference between different colours and different degrees of pigmentation)
  • Diameter >0.6cm
  • Evolution (of all of the above)
38
Q

What ‘rule’ do predominantly vertical growing melanomas follow?

A

EFG rules:

  • Elevation
  • Firm
  • Growing
39
Q

Order the melanoma subtypes most common to least common

A
  • Superficial spreading melanoma (70%)
  • Nodular melanoma
  • Lentigo maligna melanoma
  • Acral lentiginous
40
Q

Which melanoma subtype is most common?

A
  • Most common= superficial spreading melanoma
  • Second most common= nodular melanoma
41
Q

Discuss the 2WW referral criteria for melanoma

A

Refer via 2WW if person has:

  • Suspicious pigmented skin lesion that has a weighted seven-point checklist score of three or more (but if strong concern one feature is enough to warrant referral)
  • Or dermoscopy suggests malignant melanoma of the skin

Consider referral via 2WW if person has:

  • A pigmented or non-pigmented skin lesion that suggests nodular melanoma
42
Q

What investigations are done for melanoma?

A
  • Excisional biopsy with 2mm margin (GOLD STANDRARD but if not possible can do incisional biopsy)
  • Consider sentinel lymph node biopsy
  • CT TAP for pts with stage IIIB or IIIC melanoma (imaging is not routinely done for lower stages)
  • CT or MRI brain
  • Consider PET scan in stage IV melanoma
  • LDH for stage IV melanoma
43
Q

Discuss the management of melanoma

A
  • Suspicious lesions should have excision biopsy. Once diagnosis confirmed then a second surgery/wide local excision with following margins
    • In situ= 5mm
    • BT = 1mm= 1cm
    • BT >1mm - =2mm= 1-2cm
    • BT >2mm - =4mm= 2-3cm
    • BT >4mm = 3cm
  • Radical lymph node dissection if node metastasis
  • Adjuvant therapy:
    • Normally immunotherapy (PD1 inhibitors e.g. Nivolumab)
    • Targeted therapies (BRAF inhibitors (50% have BRAF mutation), MEK inhibitors)
    • Radiotherapy (not often used. Mostly used for brain)

And of course skin protection advice (cover up, sun cream etc…)

Lecturer said doesn’t respond to chemotherapy

44
Q

Discuss the prognosis of melanoma (include some of the most important prognostic factors)

A

The prognosis is highly variable, depending on the stage at diagnosis. The most important prognostic indicators are Breslow’s depth of the tumour and lymph node status.

  • In situ/stage 0= 98%
  • Stage 1= 90-95%
  • Stage II (localised disease)= 45-78%
  • Stage III (nodal metastases)= 26-69%
  • Stage IV (metastatic)= 3-10%
45
Q

Which melanoma subtype is most aggressive?

A

Nodular melanoma (the predominantly vertical growing melanoma subtype)

46
Q

What checklist is used to determine likelihood of melanoma?

A

7 point weighted checklist:

**Suspicion is greater for lesions scoring 3 points or more. However, if there are strong concerns about cancer, any one feature is adequate to prompt urgent referral under the 2-week rule.

47
Q

What is the difference between an excisional, incisional, shave & punch biopsy?

Why is excisional the gold standard for melanoma?

A

Excisional biopsy= entire tumour removed (along with small margin of normal skin around it). Do in elliptical shape to reduce risk of scarring as can design so that ellipse is in line with parallel with existing skin creases and can ensure edges of skin oppose nicely so can heal via primary intention

Incisional biopsy= part of tumour removed. Used if large lesion or if in sensitive region (e.g. eyelid, lip etc…)

Shave biopsy= samples a portion of the superficial layers of the skin and therefore is minimally invasive

Punch biopsy= a punch biopsy involves removing a small piece of skin using a circular blade called a punch (usually 6mm)

Excisional is gold standard as you are hopefully removing the whole lesion. incisional biopsy can make subsequent histopathological assessment difficult.

48
Q

State some prognostic factors that are included in biopsy report for melanoma

A
  • Breslow thickness (BT): vertical thickness of melanoma in mm
  • Clark level: level of melanoma invasion into the anatomical layers
  • Lymphatic/vascular invasion
  • Mitotic count
  • Perineural infiltration
  • Presence of ulceration

NOTE: Breslow thickness is more accurate in predicting prognosis and represents the T part of the TNM staging for melanoma

49
Q

What staging is used for melanoma?

A

TNM

(Based on primary tumour Breslow thickness, lymph node involvement & metastases)

50
Q

How common is melanoma?

A

5th most common cancer in UK

51
Q

What 3 factors will be considered during MDT to determine which type of skin biopsy pts should have?

A
  • Clinical suspicion
  • Location
  • Pt preference/ideas
52
Q

Lymphoma can present in the skin; discuss the two types of cutaneous lymphoma and how they may present in the skin

A

Two types cutaneous lymphoma:

  • cutaneous T cell lymphoma (CTCL) starts in the T cells of the skin
  • cutaneous B cell lymphoma (CBCL) starts in the B cells of the skin

CTCL is the most common type of skin lymphoma. It causes flat red patches on the skin that look like eczema and can be itchy. Several parts of the body can be affected.

CBCL is a more unusual type. People tend to have lumps on their skin in 1 or 2 areas, rather than affecting all of the body.

Yr4: Neurology & Special Senses (28 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions